Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients
出版年份 2016 全文链接
标题
Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 19, Issue 1, Pages 108-117
出版商
Wiley
发表日期
2016-09-15
DOI
10.1111/dom.12790
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes
- (2016) S. K. Paul et al. DIABETES OBESITY & METABOLISM
- Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
- (2016) K. Khunti et al. DIABETES OBESITY & METABOLISM
- Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study
- (2015) Jean-Francois Gautier et al. ADVANCES IN THERAPY
- The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study
- (2015) Sanjoy K Paul et al. Cardiovascular Diabetology
- Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
- (2015) Sanjoy K Paul et al. Cardiovascular Diabetology
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
- (2015) Caroline S. Fox et al. CIRCULATION
- Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case–control study
- (2015) M. Rigato et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
- (2015) Anoop Dinesh Shah et al. Lancet Diabetes & Endocrinology
- Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus
- (2014) Nathaniel R. Smilowitz et al. CIRCULATION
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin
- (2014) Beverley Balkau et al. DIABETES CARE
- 8. Cardiovascular Disease and Risk Management
- (2014) DIABETES CARE
- Improved real-world glycaemic outcomes with liraglutide versus other incretin-based therapies in type 2 diabetes
- (2014) W. C. Lee et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes
- (2014) Charles F. Shaefer et al. POSTGRADUATE MEDICINE
- Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
- (2014) Qian Li et al. Diabetes Therapy
- Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
- (2013) Keith L. Davis et al. CURRENT MEDICAL RESEARCH AND OPINION
- Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
- (2013) J. Vora DIABETES CARE
- Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature
- (2012) R. Balena et al. DIABETES OBESITY & METABOLISM
- Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*
- (2011) K. Y. Thong et al. DIABETES OBESITY & METABOLISM
- Novel GLP-1 receptor agonists for diabetes
- (2011) Alan J Garber EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cardiovascular safety and diabetes drug development
- (2011) Daniel J Drucker et al. LANCET
- Comparison of GE Centricity Electronic Medical Record Database and National Ambulatory Medical Care Survey Findings on the Prevalence of Major Conditions in the United States
- (2010) Albert G. Crawford et al. Population Health Management
- Intensive glucose control and macrovascular outcomes in type 2 diabetes
- (2009) F. M. Turnbull et al. DIABETOLOGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now